Background Metabolic dysfunction-associated fatty liver disease (MAFLD) is presently the
most prevalent chronic liver disorder globally that is closely linked to obesity, dyslipidemia …

Abstract Background & Aims It is unclear to what extent lifestyle and genetic factors affect
incidence of chronic liver disease (CLD) in a general population and if lifestyle affects CLD …

Non-alcoholic fatty liver disease (NAFLD) and its progressive stage, non-alcoholic
steatohepatitis (NASH), are becoming one of the most common chronic liver diseases …

BACKGROUND Several bibliometric analyses have been carried out to identify research
hotspots and trends in nonalcoholic fatty liver disease (NAFLD) research. Nonetheless …

Background: Per-and polyfluoroalkyl substances (PFASs) including perfluorooctanoic acid
(PFOA) are ubiquitous environmental contaminants. Prior analysis in the large “C8 Health …

Abstract Metabolic Dysfunction-Associated Fatty Liver Disease and Diabetes Mellitus are
two prevalent metabolic disorders that often coexist and synergistically contribute to the …

Diseases related to fatty liver, independently of alcohol consumption («non-alcoholic fatty
liver disease» or NAFLD), are increasing because of the epidemics of obesity and type 2 …

China has a high prevalence rate of Metabolic-associated fatty liver disease (MAFLD), and
there is currently limited understanding of the levels of exercise self-efficacy (ESE) among …

Background Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver
disease in the world. The increasingly sedentary lifestyle in recent years may have …

Non-alcoholic fatty liver disease (NAFLD), a complex liver disorder that can result in non-
alcoholic steatohepatitis, cirrhosis, and liver cancer, is the accumulation of fat in the liver …